Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Apple Inc. AAPL

Alternate Symbol(s):  N.AAPL

Apple designs a wide variety of consumer electronic devices, including smartphones (iPhone), tablets (iPad), PCs (Mac), smartwatches (Apple Watch), AirPods, and TV boxes (Apple TV), among others. The iPhone makes up the majority of Apple's total revenue. In addition, Apple offers its customers a variety of services such as Apple Music, iCloud, Apple Care, Apple TV+, Apple Arcade, Apple Card, and Apple Pay, among others. Apple's products run internally developed software and semiconductors, and the firm is well known for its integration of hardware, software and services. Apple's products are distributed online as well as through company-owned stores and third-party retailers. The company generates roughly 40% of its revenue from the Americas, with the remainder earned internationally.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

FSD Pharma Inc: Lucid MS Video

  rate and reply

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

   rate and reply

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings...read more

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential...read more

RE:20% drop is coming

Getting down and dirty, stock options getting assigned fast !  rate and reply

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)...read more

FSD Pharma Issues Corporate Updates

FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to...read more

iMining: First Hospital Foundation in Decentraland Metaverse

iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse   Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc...read more

RE:Russia forces are on the run

How much gold does Vlad have stowed on his yacht?  rate and reply

The Alchemy of The 21st Century has Arrived

           The Nano-Gold Revolution: The Alchemy of The 21st Century has Arrived                        ...read more

METAVERSE

According to a research report published by Brandessence Market Research, the metaverse market size reached USD 44.69 billion in 2020. and Predicted to reach USD 596.47 Billion by 2027. The metaverse...read more

20% drop is coming

Look for a 20% drop in share price over the next 2-3 months.  The geo-political landscape is not looking good in the short term for anything Apple.  rate and reply

down ...but why

oil and gold shouldnt affect us badly  rate and reply

FSD Pharma; Recapping 2021 and What to Look Forward in 2022

  rate and reply

Test Test Test

Therma Brights (TSXV:THRM) AcuVid COVID-19 Rapid Antigen Saliva Test exceeds U.S. FDAs EUA requirements Health Care, Market News TSXV:THRM $79.03M  rate and reply

FSD Pharma Inc: Lucid MS Video

FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid...read more